Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Other Non-Current Assets (2023 - 2025)

Connect Biopharma Holdings (CNTB) has disclosed Other Non-Current Assets for 3 consecutive years, with $646000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 1857.58% to $646000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $646000.0 through Dec 2025, up 1857.58% year-over-year, with the annual reading at $646000.0 for FY2025, 1857.58% up from the prior year.
  • Other Non-Current Assets hit $646000.0 in Q4 2025 for Connect Biopharma Holdings, up from $45000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $646000.0 in Q4 2025 to a low of $24000.0 in Q4 2023.
  • Historically, Other Non-Current Assets has averaged $139666.7 across 3 years, with a median of $45000.0 in 2025.
  • Biggest five-year swings in Other Non-Current Assets: soared 37.5% in 2024 and later skyrocketed 1857.58% in 2025.
  • Year by year, Other Non-Current Assets stood at $24000.0 in 2023, then skyrocketed by 37.5% to $33000.0 in 2024, then surged by 1857.58% to $646000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for CNTB at $646000.0 in Q4 2025, $45000.0 in Q3 2025, and $45000.0 in Q2 2025.